Mapsd Dual-target cTBS (Auditory Cortex and M1)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mapsd Dual-target cTBS (Auditory Cortex and M1), covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Mapsd Dual-target cTBS (Auditory Cortex and M1) for Generalized Anxiety Disorder [NA]